financetom
Business
financetom
/
Business
/
At least 18 dead in Nepal plane crash, officials say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
At least 18 dead in Nepal plane crash, officials say
Jul 24, 2024 12:32 AM

KATHMANDU, July 24 (Reuters) - At least 18 people were

killed when a small plane crashed and caught fire while it was

taking off from Nepal's capital Kathmandu on Wednesday,

officials said.

The plane was carrying two crew members and 17 technicians

to Pokhara city to repair another aircraft, officials said.

"Only the captain was rescued alive and is receiving

treatment at a hospital," said Tej Bahadur Poudyal, the

spokesman for Kathmandu's Tribhuvan International Airport.

Television visuals showed fire fighters trying to put out

the blaze and thick black smoke rising into the sky. They also

showed the plane flying a little above the runway and then

tilting before it crashed.

Other visuals showed rescue workers rummaging through the

charred remains of the plane, strewn in lush green fields.

Bodies were carried to ambulances on stretchers as local

residents looked on, the television showed.

The plane was a Bombardier, officials said, and

media reported it belonged to local Saurya Airlines. The airport

had been temporarily closed, the officials added.

Saurya operates domestic flights in Nepal with two

Bombardier CRJ-200 regional jets, both around 20 years old,

according to Flight Radar 24.

Nepal has been criticised for a poor air safety record, and

nearly 350 people have died in plane or helicopter crashes in

the Himalayan country since 2000.

The deadliest incident occurred in 1992, when a Pakistan

International Airlines Airbus crashed into a hillside while

approaching Kathmandu, killing 167 people.

Most recently, at least 72 people were killed in a Yeti

airlines crash in January 2023 that was later attributed to the

pilots mistakenly cutting off power.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Premier Signs $200 Million Accelerated Share Repurchase Deal With JPMorgan Chase
Premier Signs $200 Million Accelerated Share Repurchase Deal With JPMorgan Chase
Feb 18, 2025
09:02 AM EST, 02/18/2025 (MT Newswires) -- Premier (PINC) said Tuesday it signed accelerated share repurchase deals with JPMorgan Chase's ( JPM ) JPMorgan Chase Bank to buy back a total of $200 million of the company's class A common shares. Under the terms, Premier will pay $200 million to JPMorgan ( JPM ) and will receive initial deliveries of...
Nike, Skims Form New Brand Targeting Women's Fitness Apparel Industry
Nike, Skims Form New Brand Targeting Women's Fitness Apparel Industry
Feb 18, 2025
09:04 AM EST, 02/18/2025 (MT Newswires) -- Nike ( NKE ) said Tuesday it is partnering with Kim Kardashian-backed clothing brand Skims to form a new brand, NikeSKIMS. The new brand will focus on women's apparel, footwear, and accessories for the global fitness and activewear industry. NikeSKIMS will debut its initial collection in select U.S. retail stores and on its...
Chartwell Declares February Distribution and Provides Occupancy Update
Chartwell Declares February Distribution and Provides Occupancy Update
Feb 18, 2025
09:06 AM EST, 02/18/2025 (MT Newswires) -- Chartwell Retirement Residences (CSH-UN.TO) on Tuesday declared a monthly cash distribution of $0.051 per trust unit, payable on March 17 to unitholders of record on Feb. 28. This latest distribution is unchanged from the prior month. The company said it has seen very robust winter sales, resulting in higher January occupancy and a...
Biogen, Stoke Partner on Dravet Syndrome Investigational Drug Zorevunersen
Biogen, Stoke Partner on Dravet Syndrome Investigational Drug Zorevunersen
Feb 18, 2025
09:05 AM EST, 02/18/2025 (MT Newswires) -- Biogen (BIIB) and Stoke Therapeutics ( STOK ) said Tuesday they have partnered to develop and commercialize zorevunersen, Stoke's investigational treatment for Dravet syndrome, a rare genetic epilepsy. Stoke will receive $165 million upfront and may earn up to $385 million in milestone payments, along with royalties on sales in Biogen's territories, according...
Copyright 2023-2026 - www.financetom.com All Rights Reserved